226 related articles for article (PubMed ID: 25548579)
1. Expression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in Invasive Ductal Carcinomas of the Breast.
Seo J; Min SK; Park HR; Kim DH; Kwon MJ; Kim LS; Ju YS
J Breast Cancer; 2014 Dec; 17(4):323-31. PubMed ID: 25548579
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer--overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression.
Müller BM; Jana L; Kasajima A; Lehmann A; Prinzler J; Budczies J; Winzer KJ; Dietel M; Weichert W; Denkert C
BMC Cancer; 2013 Apr; 13():215. PubMed ID: 23627572
[TBL] [Abstract][Full Text] [Related]
3. Expression of acetylated histones H3 and H4 and histone deacetylase enzymes HDAC1, HDAC2 and HDAC6 in simple mammary carcinomas of female dogs.
Senhorello ILS; Matiz ORS; Canavari IC; Hernandez GV; Anai LA; Navarrete Ampuero RA; Pazzini JM; Prado CM; Meirelles FV; Vasconcelos RO; Tinucci-Costa EM
Front Genet; 2023; 14():1257932. PubMed ID: 38028583
[TBL] [Abstract][Full Text] [Related]
4. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features and prediction values of HDAC1, HDAC2, HDAC3, and HDAC11 in classical Hodgkin lymphoma.
Huang R; Zhang X; Sophia S; Min Z; Liu X
Anticancer Drugs; 2018 Apr; 29(4):364-370. PubMed ID: 29481474
[TBL] [Abstract][Full Text] [Related]
6. Relationship Between Histone Deacetylase 3 (HDAC3) and Breast Cancer.
Cui Z; Xie M; Wu Z; Shi Y
Med Sci Monit; 2018 Apr; 24():2456-2464. PubMed ID: 29680858
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma.
Mithraprabhu S; Kalff A; Chow A; Khong T; Spencer A
Epigenetics; 2014 Nov; 9(11):1511-20. PubMed ID: 25482492
[TBL] [Abstract][Full Text] [Related]
8. Aberrant HDAC3 expression correlates with brain metastasis in breast cancer patients.
Ma L; Qi L; Li S; Yin Q; Liu J; Wang J; She C; Li P; Liu Q; Wang X; Li W
Thorac Cancer; 2020 Sep; 11(9):2493-2505. PubMed ID: 32686908
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of histone deacetylase 2 silences progesterone receptor-mediated signaling.
Biçaku E; Marchion DC; Schmitt ML; Münster PN
Cancer Res; 2008 Mar; 68(5):1513-9. PubMed ID: 18316616
[TBL] [Abstract][Full Text] [Related]
10. Histone modifiers and marks define heterogeneous groups of colorectal carcinomas and affect responses to HDAC inhibitors in vitro.
Lutz L; Fitzner IC; Ahrens T; Geißler AL; Makowiec F; Hopt UT; Bogatyreva L; Hauschke D; Werner M; Lassmann S
Am J Cancer Res; 2016; 6(3):664-76. PubMed ID: 27152243
[TBL] [Abstract][Full Text] [Related]
11. Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis.
Weichert W; Röske A; Gekeler V; Beckers T; Ebert MP; Pross M; Dietel M; Denkert C; Röcken C
Lancet Oncol; 2008 Feb; 9(2):139-48. PubMed ID: 18207460
[TBL] [Abstract][Full Text] [Related]
12. HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma.
Ramakrishnan S; Ku S; Ciamporcero E; Miles KM; Attwood K; Chintala S; Shen L; Ellis L; Sotomayor P; Swetzig W; Huang R; Conroy D; Orillion A; Das G; Pili R
BMC Cancer; 2016 Aug; 16():617. PubMed ID: 27506904
[TBL] [Abstract][Full Text] [Related]
13. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo.
Weichert W; Röske A; Niesporek S; Noske A; Buckendahl AC; Dietel M; Gekeler V; Boehm M; Beckers T; Denkert C
Clin Cancer Res; 2008 Mar; 14(6):1669-77. PubMed ID: 18347167
[TBL] [Abstract][Full Text] [Related]
14. Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer.
Saji S; Kawakami M; Hayashi S; Yoshida N; Hirose M; Horiguchi S; Itoh A; Funata N; Schreiber SL; Yoshida M; Toi M
Oncogene; 2005 Jun; 24(28):4531-9. PubMed ID: 15806142
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast*.
Zhang Z; Yamashita H; Toyama T; Sugiura H; Ando Y; Mita K; Hamaguchi M; Hara Y; Kobayashi S; Iwase H
Breast Cancer Res Treat; 2005 Nov; 94(1):11-6. PubMed ID: 16172792
[TBL] [Abstract][Full Text] [Related]
16. HDAC6 expression is correlated with better survival in breast cancer.
Zhang Z; Yamashita H; Toyama T; Sugiura H; Omoto Y; Ando Y; Mita K; Hamaguchi M; Hayashi S; Iwase H
Clin Cancer Res; 2004 Oct; 10(20):6962-8. PubMed ID: 15501975
[TBL] [Abstract][Full Text] [Related]
17. The immunohistochemical expression and potential prognostic value of HDAC6 and AR in invasive breast cancer.
Li C; Cao L; Xu C; Liu F; Xiang G; Liu X; Jiao J; Niu Y
Hum Pathol; 2018 May; 75():16-25. PubMed ID: 29180246
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alpha.
Kawai H; Li H; Avraham S; Jiang S; Avraham HK
Int J Cancer; 2003 Nov; 107(3):353-8. PubMed ID: 14506733
[TBL] [Abstract][Full Text] [Related]
19. A Decrease of Histone Deacetylase 6 Expression Caused by Helicobacter Pylori Infection is Associated with Oncogenic Transformation in Gastric Cancer.
He Q; Li G; Wang X; Wang S; Hu J; Yang L; He Y; Pan Y; Yu D; Wu Y
Cell Physiol Biochem; 2017; 42(4):1326-1335. PubMed ID: 28700998
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy.
Weichert W; Röske A; Gekeler V; Beckers T; Stephan C; Jung K; Fritzsche FR; Niesporek S; Denkert C; Dietel M; Kristiansen G
Br J Cancer; 2008 Feb; 98(3):604-10. PubMed ID: 18212746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]